Skip to main content

Clinical Trials

Learn about clinical trials for new diabetes treatments, technology, and care programs that may be recruiting people with diabetes in your area.

New trial aims to make U500 (more concentrated) insulin easier to take.
Currently recruiting in people newly diagnosed with type 1.
Testing TypeZero’s inControl artificial pancreas, six months at a time.
What are the implications for other injected GLP-1 agonist drugs?
Program designed for Medicaid and uninsured individuals at risk for diabetes. Omada Health recently announced the launch of Prevent for Underserved Populations. The new...
Enrolling at over 140 sites worldwide. Can it reduce A1c and insulin use and improve time-in-range?
Find nearby T1D, T2D, gestational diabetes, and complications trials with new clinical trials matching tool launched by JDRF and TrialReach
A six-month study of Diasome Pharmaceuticals’ HDV Insulin in Type 1 Diabetes
Recruiting participants in Boston at the Joslin Diabetes Center
A real-world trial in 3,000+ participants currently enrolling participants with type 2 diabetes
A six-week study of Tandem’s first automated insulin delivery device with Dexcom’s G5 CGM
Trial results testing sotagliflozin and Farxiga in type 1 diabetes show greater A1c lowering and weight loss, plus continued conversation about small risk of DKA
Seeking participants with type 2 diabetes to investigate the effects of semaglutide on heart health
Comparing Medtronic’s MiniMed 670G to injections and pumps in people with type 1 diabetes, with and without CGM; enrollment to open in May at some trial locations
Learn more about the All of Us Research Program, a massive national effort to collect individual health data to support precision medicine research
Two new studies will investigate whether SGLT-2 inhibitor Jardiance impacts heart failure in people with and without diabetes. Jardiance is already approved to lower A1C...
A new study is investigating whether higher doses of injectable GLP-1 agonist Trulicity (dulaglutide) are more effective; it is recruiting 1,800 participants with type 2...
A new trial will test if the once-weekly injectable, Bydureon, is also safe and effective in adolescents.
Recruiting now! This major study will support FDA submission of Tandem’s t:slim X2 with Control-IQ and Dexcom G6 in people with type 1 ages 14 and up; includes automatic...
Phase 3 clinical trial currently recruiting 400 adults with type 2 diabetes

Pages